ABG Sundal Collier acted as joint global coordinator and bookrunner in the IPO of Silex Microsystems

Silex Microsystems AB (the “Company”), the leading pure-play MEMS foundry globally, has successfully completed its IPO on Nasdaq Stockholm with the first day of trading on 7 May 2026. Headquartered in Järfälla, Sweden, Silex is the global leader in pure-play MEMS manufacturing, serving a broad base of leading technology customers across applications such as medical technology, telecommunications, data centres and automotive. The MEMS market is supported by strong structural growth driven by trends including AI, IoT, automation and autonomous systems. For the year ended 31 December 2025, Silex’s net sales were SEK 1,385 million with an EBIT of SEK 368 million, reflecting average annual net sales growth of 17 percent since 2015.

The offering comprised newly issued ordinary shares providing the Company with gross proceeds of approximately SEK 1,000 million, alongside a secondary component, and was priced at a market capitalisation of approximately SEK 8.9 billion. The offering attracted strong interest from both Nordic and international institutional investors and was multiple times oversubscribed. Creades AB (publ), AFA Insurance, Tredje AP-fonden, one or more funds and/or accounts managed by Capital Research Global Investors, Swedbank Robur Fonder AB, Fjärde AP-fonden, Andra AP-fonden (AP2), Fidelity International and Carnegie Fonder acted as cornerstone investors in the transaction, undertaking to acquire shares of up to SEK 1,501 million, representing approximately 75 percent of the offering.

The IPO follows ABG Sundal Collier’s role as sole financial adviser to Silex Microsystems and its previous majority owner Sai Microelectronics on the sale of the Company in 2025 to a Swedish consortium led by Bure Equity and Creades, including Grenspecialisten, 3S Invest, SEB-Stiftelsen and TomEnterprise, re-establishing Silex as a Swedish majority-owned company. ABGSC is proud to have acted as Joint Global Coordinator and Joint Bookrunner in the transaction, and as sole financial adviser in the 2025 sale of Silex Microsystems to the Bure- and Creades-led consortium.